Antifibrinolytic treatment in subarachnoid hemorrhage

Completed

Phase N/A Results

Summary of Purpose

To determine whether treatment with the antifibrinolytic agent tranexamic acid in patients with subarachnoid hemorrhage improves outcome by preventing rebleeding.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 12 April 2001.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Dutch Heart Foundation

Trial Design

Randomized, double-blind, placebo-controlled trial of 479 patients at 4 centers.

Contacts

Not available